International committee communications. Report of the subgroup on fibrinolytic inhibitors, subcommittee on fibrinolysis.
作者信息
Hedner U
出版信息
Thromb Haemost. 1979 May 25;41(3):622-4.
PMID:37610
Abstract
摘要
相似文献
1
International committee communications. Report of the subgroup on fibrinolytic inhibitors, subcommittee on fibrinolysis.
Thromb Haemost. 1979 May 25;41(3):622-4.
2
Fibrinolytic inhibitors in human seminal plasma.人精浆中的纤溶酶抑制剂。
Experientia. 1974 Oct 15;30(10):1113-4. doi: 10.1007/BF01923638.
3
On the regulation and control of fibrinolysis. Edward Kowalski Memorial Lecture.论纤维蛋白溶解的调控。爱德华·科瓦尔斯基纪念讲座。
Thromb Haemost. 1980 Jun 18;43(2):77-89.
4
Studies on human urinary enzymes and inhibitors. Concentration method and characterization.人体尿液酶与抑制剂的研究。浓缩方法与特性
J Biochem. 1978 Jan;83(1):141-7. doi: 10.1093/oxfordjournals.jbchem.a131885.
5
[Fibrinolytic system in patients with nephrotic syndrome].[肾病综合征患者的纤溶系统]
Ter Arkh. 1976;40(2):89-99.
6
The behavior of alpha2-plasmin inhibitor in fibrinolytic states.α2-纤溶酶抑制剂在纤溶状态下的行为。
J Clin Invest. 1977 Aug;60(2):361-9. doi: 10.1172/JCI108784.
7
Staphylokinase reduces plasmin formation by endogenous plasminogen activators.葡萄球菌激酶可减少内源性纤溶酶原激活剂形成纤溶酶。
Eur J Haematol. 2008 Jul;81(1):8-17. doi: 10.1111/j.1600-0609.2008.01066.x. Epub 2008 Mar 10.
8
[Position and developmental trends in fibrinolytic therapy].[纤维蛋白溶解疗法的地位及发展趋势]
Folia Haematol Int Mag Klin Morphol Blutforsch. 1986;113(1-2):6-17.
9
Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.健康与疾病中的纤维蛋白溶解：系统性红斑狼疮中的严重异常
J Lab Clin Med. 1984 Dec;104(6):962-76.
10
The inhibitory effect of plasma inhibitor on plasmin activated with streptokinase or urokinase.血浆抑制剂对链激酶或尿激酶激活的纤溶酶的抑制作用。
Nihon Seirigaku Zasshi. 1977;39(5):112-4.
Zotero 插件